Targeted radionuclide therapy has become increasingly prominent as a nuclear medicine
subspecialty. For many decades, treatment with radionuclides has been mainly restricted to …

Targeted radiotherapy is an evolving and promising modality of cancer treatment. The killing
of cancer cells is achieved with the use of biological vectors and appropriate radionuclides …

Radionuclide therapy (RNT) based on the concept of delivering cytotoxic levels of radiation
to disease sites is one of the rapidly growing fields of nuclear medicine. Unlike conventional …

The last three decades have provided opportunities to explore the potential of treating
malignant diseases with antibodies or other targeting molecules labelled with nuclides …

Since the first introduction of sodium iodide I-131 for use with thyroid patients almost 80
years ago, more than 50 radiopharmaceuticals have reached the markets for a wide range …

The growing interest in targeted radionuclide therapy (TRT) for a broad range of applications
is shared by a diverse group of medical professionals, including but not limited to physicians …

Radiopharmaceutical therapy involves the use of radionuclides that are either conjugated to
tumor-targeting agents (eg, nanoscale constructs, antibodies, peptides, and small …

In recent years, there has been a proliferation in the development of targeted radionuclide
cancer therapy. It is now possible to use baseline clinical and imaging assessments to …

The aim of this review was to assess recent progress in targeted radionuclide tumor therapy,
focusing on the best delivery strategies. A literature search was conducted in PubMed, Web …

The concept of targeted radionuclide therapy (TRT) relies on the use of injected nuclear
medicine as treating agents, targeted at the cellular or molecular level. The growth of the …